A research paper authored by University of Florida College of Pharmacy faculty members and trainees has received an Honourable Mention for The Ronald D. Mann Best Paper Award for 2025.
The paper, “High-Throughput Screening for Prescribing Cascades Among Real-World Angiotensin-Converting Enzyme Inhibitor Initiators,” was co-authored by Asinamai M. Ndai, Kayla Smith, Shailina Keshwani, Jaeyoung Choi, Michael Luvera, Julia Hunter, Rebecca Galvan, Tanner Beachy, Matt Molk, Shannon Wright, Marianna Calvet, Carl J. Pepine, Stephan Schmidt, Scott M. Vouri and Earl J. Morris.
The study analyzed claims data from more than 300,000 Medicare beneficiaries and identified 42 potential prescribing cascades associated with angiotensin-converting enzyme inhibitors, or ACEIs. A prescribing cascade occurs when a medication side effect is mistaken for a new medical condition and results in the prescription of an additional drug. The findings may help clinicians better identify medication-related adverse effects and reduce unnecessary prescribing.
The Ronald D. Mann Best Paper Award is given annually to the best paper published in the journal Pharmacoepidemiology & Drug Safety. The prize is co-sponsored by the publisher, John Wiley & Sons, Ltd., and the International Society for Pharmacoepidemiology, or ISPE. It was awarded for the first time at the 2002 ISPE meeting in Edinburgh, Scotland.
The award will be formally presented during the 42nd ISPE Annual Meeting, scheduled for Aug. 29 – Sept. 2, in Milan, Italy.